3,4-Methylenedioxyphentermine
Chemical compound
From Wikipedia, the free encyclopedia
MDPH, also known as 3,4-methylenedioxyphentermine or as α-methyl-MDA, is a psychoactive drug of the amphetamine family.[1] MDPH was first synthesized by Alexander Shulgin.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPH.[1]
- None
| |
| Clinical data | |
|---|---|
| Other names | MDP; MDPH; 3,4-Methylenedioxyphentermine; 3,4-Methylenedioxy-α,α-dimethylphenethylamine; 3,4-Methylenedioxy-α-methylamphetamine; α-Methyl-MDA |
| Routes of administration | Oral[1] |
| Drug class | Psychoactive drug |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 3–5 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H15NO2 |
| Molar mass | 193.246 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDPH's dose as 160 to 240 mg orally and its duration as 3 to 5 hours.[1] MDPH's effects are very similar to those of MDA: they both are smooth and "stoning," and do not cause any visuals.[1] They also alter dreams and dream patterns.[1] But it is said to have none of the magic of MDMA.[1] Shulgin describes MDPH as a promoter; it promotes the effects of other drugs, similarly to 2C-D.[1]
Chemistry
Synthesis
The chemical synthesis of MDPH has been described.[1]
Analogues
The N-methyl derivative, 3,4-methylenedioxy-N-methylphentermine (MDMPH), has been described by Shulgin as lacking MDMA-like effects.[2] Accordingly, MDMPH, as well as MDPH, were found to be inactive as serotonin releasing agents in vitro.[2][3]
Society and culture
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[4]